Tag: Sanjay Suri
GENERAL Morepen Lab Kicks Off Commercial Execution Of ₹825-Cr CDMO Order

Morepen Laboratories has completed its first commercial dispatch worth ₹50 crore under its ₹825- crore CDMO mandate and expects supplies of around ₹225 crore in Q2 FY2026-27 as it expands manufacturing capacity. Morepen Laboratories Ltd has commenced commercial execution of its recently announced ₹825 crore Contract Development and Manufacturing Organisation (CDMO) mandate by completing its […]

CW Bureau · Jul 1, 2026
GENERAL Morepen Laboratories Q4 PAT Jumps 69%, Revenue Up 22% At ₹472 Cr

Morepen Laboratories, a vertically integrated pharmaceutical and healthcare company, reported a strong performance for Q4 FY26, with net profit rising 69% year-on-year to ₹20 crore, while gross revenue increased 22% YoY to ₹472 crore. The company said revenue growth during the quarter was driven by strong export momentum and continued expansion in its Medical Devices […]

CW Bureau · May 27, 2026